Since the role of ANO1 in gut motility has been demonstrated in mice homozygous for the null ANO1 allele [112,113], we hypothesize that activating ANO1 might have a therapeutic effect in patients with CF who suffer from intestinal obstruction syndromes. This evidence concerns the gene ANO1 and cystic fibrosis.